Last reviewed · How we verify
AZD0486 IV
At a glance
| Generic name | AZD0486 IV |
|---|---|
| Also known as | TNB-486 |
| Sponsor | AstraZeneca |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study of AZD0486 in Subjects With B-Cell Non-Hodgkin Lymphoma (PHASE1)
- A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies (PHASE1, PHASE2)
- AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |